Close

Labetuzumab (TAB-033)

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human CEACAM5 Therapeutic Antibody (CEA-Cide) TAB-033 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Mab to CEA. Recombinant monoclonal antibody to CEA. Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer.
  • Target
  • CEACAM5
  • Type
  • IgG
  • Immunogen
  • Purified CEA emulsified in complete Freund`s Adjuvant.
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in ELISA, IP, FC, FuncS, Neut, IF, ICC and most other immunological methods.
  • CAS
  • 219649-07-7
  • Trade name
  • cea-cide
  • Specificity
  • Tested positive against native human antigen.
  • Protein Construction
  • Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal huMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer
  • Predicted N terminal
  • H chain: EVAQLVES; L chain: DIQLTQS
  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.
  • Size
  • 1mg
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

BACKGROUND

  • Antigen Description
  • Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins.
  • Synonyms
  • CEACAM5; carcinoembryonic antigen-related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100; DKFZp781M2392;

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us